Evidence map›Paper›PMID 37368398›Full record

ArticleJAMA network open2023

Exposure to Agent Orange and Risk of Bladder Cancer Among US Veterans.

Stephen B Williams, Jessica L Janes, Lauren E Howard, Ruixin Yang, Amanda M De Hoedt, Jacques G Baillargeon, Yong-Fang Kuo, Douglas S Tyler, Martha K Terris, Stephen J Freedland

Open access · goldAbstract read
In one paragraph

Article in JAMA network open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Stephen B WilliamsDivision of Urology, Department of Surgery, The University of Texas Medical Branch at Galveston.
Jessica L JanesUrology Section, Department of Surgery, Durham Veterans Affairs Medical Center, Durham, North Carolina.
Lauren E HowardUrology Section, Department of Surgery, Durham Veterans Affairs Medical Center, Durham, North Carolina.
Ruixin YangUrology Section, Department of Surgery, Durham Veterans Affairs Medical Center, Durham, North Carolina.
Amanda M De HoedtUrology Section, Department of Surgery, Durham Veterans Affairs Medical Center, Durham, North Carolina.
Jacques G BaillargeonDivision of Epidemiology, Department of Medicine, Sealy Center on Aging, The University of Texas Medical Branch at Galveston.
Yong-Fang KuoDivision of Epidemiology, Department of Medicine, Sealy Center on Aging, The University of Texas Medical Branch at Galveston.
Douglas S TylerDepartment of Surgery, The University of Texas Medical Branch at Galveston.
Martha K TerrisSection of Urology, Augusta University, Augusta, Georgia.
Stephen J FreedlandUrology Section, Department of Surgery, Durham Veterans Affairs Medical Center, Durham, North Carolina.
Durham VA Medical Center · USThe University of Texas Medical Branch at Galveston · USCharlie Norwood VA Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: To date, limited data exist regarding the association between Agent Orange and bladder cancer, and the Institute of Medicine concluded that the association between exposure to Agent Orange and bladder cancer outcomes is an area of needed research. Objective: To examine the association between bladder cancer risk and exposure to Agent Orange among male Vietnam veterans. Design, Setting, and Participants: This nationwide Veterans Affairs (VA) retrospective cohort study assesses the association between exposure to Agent Orange and bladder cancer risk among 2 517 926 male Vietnam veterans treated in the VA Health System nationwide from January 1, 2001, to December 31, 2019. Statistical analysis was performed from December 14, 2021, to May 3, 2023. Exposure: Agent Orange. Main Outcomes and Measures: Veterans exposed to Agent Orange were matched in a 1:3 ratio to unexposed veterans on age, race and ethnicity, military branch, and year of service entry. Risk of bladder cancer was measured by incidence. Aggressiveness of bladder cancer was measured by muscle-invasion status using natural language processing. Results: Among the 2 517 926 male veterans (median age at VA entry, 60.0 years [IQR, 56.0-64.0 years]) who met inclusion criteria, there were 629 907 veterans (25.0%) with Agent Orange exposure and 1 888 019 matched veterans (75.0%) without Agent Orange exposure. Agent Orange exposure was associated with a significantly increased risk of bladder cancer, although the association was very slight (hazard ratio [HR], 1.04; 95% CI, 1.02-1.06). When stratified by median age at VA entry, Agent Orange was not associated with bladder cancer risk among veterans older than the median age but was associated with increased bladder cancer risk among veterans younger than the median age (HR, 1.07; 95% CI, 1.04-1.10). Among veterans with a diagnosis of bladder cancer, Agent Orange was associated with lower odds of muscle-invasive bladder cancer (odds ratio [OR], 0.91; 95% CI, 0.85-0.98). Conclusions and Relevance: In this cohort study among male Vietnam veterans, there was a modestly increased risk of bladder cancer-but not aggressiveness of bladder cancer-among those exposed to Agent Orange. These findings suggest an association between Agent Orange exposure and bladder cancer, although the clinical relevance of this was unclear.

Indexed as

Polychlorinated DibenzodioxinsUrinary Bladder NeoplasmsVeterans2,4,5-Trichlorophenoxyacetic Acid2,4-Dichlorophenoxyacetic AcidAgent OrangeCohort StudiesHumansMaleMiddle AgedRetrospective Studies2,4,5-Trichlorophenoxyacetic Acid2,4-Dichlorophenoxyacetic AcidAgent OrangePolychlorinated Dibenzodioxins

Identifiers

PMID37368398
PMCPMC10300690
OpenAlexW4382182405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.